Prospects for the application of pharmacoeconomic analysis in veterinary

Abstract

Currently, the healthcare system of the Russian Federation and veterinary legislation are undergoing a stage of systemic changes in order to meet modern requirements and fulfill the tasks assigned to it. More than 100 new medicines are registered every year, and the demand for veterinary services in large cities is increasing. There is a need to find the optimal therapy at the lowest price. Pharmacoeconomics offers various methods that help select the best treatment option that is the most cost-effective. This contributes to capacity building as it helps optimize the resources needed by organizations and communities and various commissions to adapt and improve their capabilities. The purpose of our study was to study the main indicators and existing methods for assessing the effectiveness of a drug from an economic point of view. The main methods adopted in different countries and validated are QALY, EuroQoL group questionnaire. Thus, in medical articles, such indicators as Cost-utility analysis, Willingness-to-pay threshold, Budget impact analysis are often found. Our recommended set of guidelines can become the basis for further discussion and help determine the final set for official inclusion in the Russian regulatory framework for assessing the use of pharmacological agents in veterinary medicine. This recommendation will be useful both for the manufacturers themselves, and for experts who are members of the authorities that control pharmaceutical turnover in the Russian Federation. Which in the future will serve as the foundation for creating a common basis for the EAEU countries in the system of circulation of medicines in veterinary practice.